Merit Medical Systems (MMSI) Received its Third Buy in a Row


After Raymond James and Oppenheimer gave Merit Medical Systems (NASDAQ: MMSI) a Buy rating last month, the company received another Buy, this time from Canaccord Genuity. Analyst Jason Mills maintained a Buy rating on Merit Medical Systems yesterday and set a price target of $42.00. The company’s shares closed last Monday at $38.75.

According to TipRanks.com, Mills is a top 100 analyst with an average return of 22.2% and a 68.7% success rate. Mills covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Irhythm Technologies, and Intuitive Surgical.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Merit Medical Systems with a $37.00 average price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $63.64 and a one-year low of $19.50. Currently, Merit Medical Systems has an average volume of 744.4K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Merit Medical Systems, Inc. engages in the manufacture and market of proprietary disposable medical devices. It operates through Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts